ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	18/177	191/7206	8.68893580127e-07
ko04657	IL-17 signaling pathway	11/177	87/7206	7.968178194e-06
ko04072	Phospholipase D signaling pathway	15/177	197/7206	9.26257497066e-05
ko04380	Osteoclast differentiation	12/177	134/7206	0.000103238170863
ko04662	B cell receptor signaling pathway	9/177	88/7206	0.000286142755182
ko04014	Ras signaling pathway	17/177	279/7206	0.000472047678134
ko04668	TNF signaling pathway	10/177	120/7206	0.000697402696446
ko05215	Prostate cancer	9/177	111/7206	0.00156203486276
ko04621	NOD-like receptor signaling pathway	11/177	157/7206	0.0016086796005
ko05231	Choline metabolism in cancer	10/177	134/7206	0.00163097637346
ko04933	AGE-RAGE signaling pathway in diabetic complications	10/177	135/7206	0.00172474767139
ko04725	Cholinergic synapse	11/177	160/7206	0.0018720175128
ko04658	Th1 and Th2 cell differentiation	8/177	96/7206	0.00238189607944
ko04064	NF-kappa B signaling pathway	8/177	96/7206	0.00238189607944
ko05164	Influenza A	11/177	167/7206	0.00262497595104
ko04750	Inflammatory mediator regulation of TRP channels	9/177	122/7206	0.00299563276827
ko05161	Hepatitis B	11/177	173/7206	0.00345042416372
ko04062	Chemokine signaling pathway	12/177	201/7206	0.00382825391815
ko05160	Hepatitis C	10/177	153/7206	0.0043028557417
ko04024	cAMP signaling pathway	15/177	279/7206	0.00433096777325
ko05031	Amphetamine addiction	7/177	91/7206	0.00684907438789
ko05167	Kaposi's sarcoma-associated herpesvirus infection	11/177	191/7206	0.00723424436574
ko04068	FoxO signaling pathway	10/177	167/7206	0.00790098034661
ko04916	Melanogenesis	9/177	142/7206	0.00808547648522
ko04650	Natural killer cell mediated cytotoxicity	7/177	97/7206	0.00961986344973
ko04666	Fc gamma R-mediated phagocytosis	8/177	122/7206	0.0101089641501
ko00564	Glycerophospholipid metabolism	7/177	99/7206	0.0107037317644
ko04659	Th17 cell differentiation	7/177	106/7206	0.0152005928273
ko04960	Aldosterone-regulated sodium reabsorption	4/177	41/7206	0.0175620143603
ko00140	Steroid hormone biosynthesis	4/177	41/7206	0.0175620143603
ko04931	Insulin resistance	8/177	137/7206	0.0192842356723
ko04917	Prolactin signaling pathway	6/177	87/7206	0.0197635902229
ko04070	Phosphatidylinositol signaling system	7/177	112/7206	0.020011377816
ko04919	Thyroid hormone signaling pathway	8/177	143/7206	0.0242479044665
ko00966	Glucosinolate biosynthesis	1/177	1/7206	0.0245628642798
ko04911	Insulin secretion	7/177	117/7206	0.0247624424325
ko05202	Transcriptional misregulation in cancer	10/177	188/7206	0.0259392119506
ko04912	GnRH signaling pathway	7/177	122/7206	0.0302373269144
ko04211	Longevity regulating pathway	7/177	123/7206	0.0314228208168
ko04066	HIF-1 signaling pathway	7/177	123/7206	0.0314228208168
ko05030	Cocaine addiction	5/177	73/7206	0.0331674071405
ko04724	Glutamatergic synapse	8/177	152/7206	0.0332799358355
ko04620	Toll-like receptor signaling pathway	6/177	100/7206	0.0360491345964
ko04922	Glucagon signaling pathway	7/177	128/7206	0.0378190515036
ko04020	Calcium signaling pathway	12/177	265/7206	0.0392992388559
ko04930	Type II diabetes mellitus	4/177	54/7206	0.042984634489
ko04630	Jak-STAT signaling pathway	7/177	132/7206	0.0435138531266
ko04925	Aldosterone synthesis and secretion	6/177	105/7206	0.0440946089539
ko05214	Glioma	5/177	79/7206	0.0443249573447
ko04015	Rap1 signaling pathway	12/177	278/7206	0.0478124716675
ko05200	Pathways in cancer	19/177	492/7206	0.0479140863128
ko05321	Inflammatory bowel disease (IBD)	4/177	56/7206	0.0480977544209
ko05230	Central carbon metabolism in cancer	5/177	81/7206	0.0484878785844
ko00254	Aflatoxin biosynthesis	1/177	2/7206	0.0485257196616
ko04080	Neuroactive ligand-receptor interaction	17/177	423/7206	0.049183023377
ko00760	Nicotinate and nicotinamide metabolism	3/177	34/7206	0.0499845137748